Zimmer Biomet Holdings Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zimmer Biomet Holdings Inc. (ZBH) shares fell 2.81% to $91.12 on Friday, underperforming the broader market and some competitors like Johnson & Johnson. The stock remains 15.86% below its 52-week high of $108.29 reached in August.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. (ZBH) slipped 2.81% to $91.12 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
Zimmer Biomet Holdings Inc. closed 15.86% short of its 52-week high of $108.29, which the company reached on August 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.23% to $253.04, Medtronic PLC (MDT) fell 0.43% to $83.20, and Stryker Corp. (SYK) fell 3.42% to $319.87.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1708ET